Alberto Sobrero

6PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 05, 2025
Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: An Analysis From the Aide et Recherche en Cancérologie Digestive Database.

Jean-Baptiste Bachet, Aimery de Gramont, Morteza Raeisi

|Nov 22, 2024
Intermittent or Continuous Panitumumab Plus Fluorouracil, Leucovorin, and Irinotecan for First-Line Treatment of RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The IMPROVE Trial.

Antonio Avallone, Francesco Giuliani, Alfonso De Stefano

|Mar 28, 2024
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.

Claire Gallois, Qian Shi, Levi D Pederson

|Oct 31, 2022
You're Cured Till You're Not: Should Disease-Free Survival Be Used as a Regulatory or Clinical End Point for Adjuvant Therapy of Cancer?

Alberto F Sobrero, Alessandro Pastorino, John R Zalcberg

|Oct 28, 2022
Prognostic Impact of Early Treatment and Oxaliplatin Discontinuation in Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 11 Adjuvant Trials.

Claire Gallois, Qian Shi, Jeffrey P Meyers

|Nov 09, 2021
Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.

Elisa Fontana, Jeff Meyers, Alberto Sobrero

Pageof 1

Frequent Collaborators

4 joint publications

Thierry André

4 joint publications

Qian Shi

4 joint publications

Takayuki Yoshino

3 joint publications

Timothy J Iveson